In melanoma hypoxic setting, the upregulation of hypoxia-inducible factor (HIF)-1α, the main transcriptional factor that allows cellular adaptation to hypoxia, is associated with vascular endothelial growth factor (VEGF) expression, neovascularization, poor prognosis, and resistance to therapy [1]–[4]. The gene discussed is VEGFA; the disease is melanoma.